WELCOME TOAI-RISE LABORATORY
A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea Investigative and Clinical Urology, 2025, v.66 no.- , 87-96
Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data 약 학 회 지, 2025, v.69 no.2 , 125-134
COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea KIDNEY RESEARCH AND CLINICAL PRACTICE, 2025, v.44 no.3 , 522-533
Clinician guidance in digital therapeutics for panic disorder: Meta-analytic dissection and implications for regulatory framing and scalable deployment JOURNAL OF ANXIETY DISORDERS, 2025, v.115 no.- , 103074-103074
Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis HELICOBACTER, 2025, v.30 no.5 , 70081-70081
Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6 , 70063-70063
Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs EXPERT OPINION ON DRUG SAFETY, 2025, v.24 no.8 , 899-907
Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records PLOS ONE, 2025, v.20 no.1 , 0-0
Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy YONSEI MEDICAL JOURNAL, 2025, v.66 no.11 , 713-721
Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study Therapeutic Advances in Gastroenterology, 2025, v.18 no.0 , 0-0
Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort SCIENTIFIC REPORTS, 2025, v.15 no.1 , 23490-23490
Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness CLINICAL AND MOLECULAR HEPATOLOGY, 2025, v.31 no.1 , 166-178
수원시 거주자의 혈압 및 혈당 인지율의 지역 간 격차와 관련 요인: 지역사회건강조사 자료를 활용한 분석 보건의료기술평가, 2025, v.13 no.1 , 22-30
Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson’s Disease CLINICAL THERAPEUTICS, 2024, v.46 no.9 , 670-676
Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer FUTURE ONCOLOGY, 2024, v.20 no.39 , 3245-3256
Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, v.17 no.4 , 13801-13801
Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, v.39 no.6 , 967-978
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, v.39 no.4 , 240-249
Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study CURRENT MEDICAL RESEARCH AND OPINION, 2024, v.40 no.12 , 2155-2162